Our goal is to target global markets with innovative PCR and RT-PCR products, custom oligonucleotide synthesis, monoclonal antibody development, and comprehensive kinase inhibitor profiling services.
Diversified biotech, that is DIANA Biotechnologies!
About our focus
In DIANA Biotechnologies we combine 4 segments of interest: Molecular biology reagents for life science and diagnostic labs, monoclonal antibody development, unique diagnostic projects and drug discovery services. All together is possible based on two things: We are experts in PCR technologies and our proprietary DIANA technology!
Life Science: Our expertise in PCR and RT-PCR based on 6+ million Covid-19 tests allowed us to create a robust and broad portfolio of PCR and RT-PCR mixes, unique enzymes and RNase inhibitors!
Monoclonal Antibodies: The DIANA-Ab technology is the core of our antibody development. Thanks to this we develop mAbs with unprecedented affinity and selectivity even against small molecules.
Ultrasensitive Diagnostics of Sepsis: Our PCR sepsis solution provides the most sensitive solution with results in less than 2 hours.
Drug Discovery Services: We offer kinase inhibitor profiling panels with coverage of +230 known kinases with the best possible prices. Pick the panel that would suit your needs.
Segments
We provide innovative solutions for diagnostic and academic labs, develop monoclonal antibodies, and offer drug discovery services.
ISO 13485
Our R&D and manufacturing is certified by high standards of ISO 13485
Countries covered
Our products are now available in 18 European countries and the count is still increasing!
Contact us!
NEWS
INTERESTED IN COLLABORATION?
CFO | COO
Martin Dienstbier
Contact us